Venture Certified
| 혁신성장유형 | 2024-04-02 ~ 2027-04-01 | 20240402030015 | 2024-04-02 |
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 0.0B | 0.0B |
| Operating Profit | -6.4B | -6.3B | -2.6B |
| Net Profit | -6.6B | -6.5B | -2.6B |
| Total Assets | 6.8B | 6.7B | 7.6B |
| Total Liabilities | 2.5B | 5.7B | 0.2B |
| Total Equity | 4.3B | 0.9B | 7.4B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -6B
3 Consecutive Years of Net Loss
▲ 0.0%
▼ 44.6%
▼ 81.1%
▲ 57.7%
| Name | Position | Role |
|---|---|---|
| 박해준, 김헌진 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 용인시",
"ceo_name": "박해준, 김헌진",
"certificate": [
{
"cert_number": "20240402030015",
"changes": "",
"disclosure_date": "2024-04-02",
"first_cert_date": "2024-04-02",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2024-04-02 ~ 2027-04-01"
}
],
"company_name": "(주)엠피케이바이오텍",
"corp_no": "134511-*******",
"financials": {
"2022": {
"capital_stock": 1000000000,
"cost_of_sales": 0,
"current_assets": 121174000,
"current_liabilities": 15841000,
"gross_profit": 0,
"net_income": -259033000,
"net_income_bs": -259033000,
"non_current_assets": 635634000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 81000,
"operating_profit": -259114000,
"revenue": 0,
"sga_expenses": 259114000,
"total_assets": 756808000,
"total_equity": 740967000,
"total_liabilities": 15841000
},
"2023": {
"capital_stock": 1000000000,
"cost_of_sales": 0,
"current_assets": 29491000,
"current_liabilities": 573813000,
"gross_profit": 0,
"net_income": -646963000,
"net_income_bs": -646963000,
"non_current_assets": 638326000,
"non_current_liabilities": 0,
"non_operating_expenses": 14838000,
"non_operating_income": 67000,
"operating_profit": -632192000,
"revenue": 0,
"sga_expenses": 632192000,
"total_assets": 667817000,
"total_equity": 94004000,
"total_liabilities": 573813000
},
"2024": {
"capital_stock": 2000000000,
"cost_of_sales": 0,
"current_assets": 43322000,
"current_liabilities": 249483000,
"gross_profit": 291000,
"net_income": -657484000,
"net_income_bs": -657484000,
"non_current_assets": 636167000,
"non_current_liabilities": 0,
"non_operating_expenses": 13186000,
"non_operating_income": 68000,
"operating_profit": -644366000,
"revenue": 291000,
"sga_expenses": 644657000,
"total_assets": 679489000,
"total_equity": 430006000,
"total_liabilities": 249483000
}
},
"industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
"investment": [],
"main_products": "체외진단시약",
"phone": "02-6949-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |